These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 6996445

  • 21. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 22. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH, Gelder MG.
    Adv Biochem Psychopharmacol; 1980 Jul; 24():599-602. PubMed ID: 7405678
    [No Abstract] [Full Text] [Related]

  • 23. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M, Alvarez C, Herlin S.
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [Abstract] [Full Text] [Related]

  • 24. High vs standard dosage fluphenazine HCL in acute schizophrenia.
    Donlon PT, Meadow A, Tupin JP, Wahba M.
    J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-acting phenothiazines for treatment of schizophrenia.
    Med Lett Drugs Ther; 1976 Jan 16; 18(2):6-7. PubMed ID: 1107791
    [No Abstract] [Full Text] [Related]

  • 29. Controlled trial of depot fluphenazine in out-patient schizophrenics.
    Crawford R, Forrest A.
    Br J Psychiatry; 1974 Apr 16; 124(0):385-91. PubMed ID: 4599422
    [No Abstract] [Full Text] [Related]

  • 30. The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics [proceedings].
    Goldberg SC, Shenoy RS, Sadler A, Hamer R, Ross B.
    Psychopharmacol Bull; 1981 Jan 16; 17(1):116-7. PubMed ID: 7232638
    [No Abstract] [Full Text] [Related]

  • 31. Pimozide in the treatment of chronic schizophrenic patients.
    Chouinard G, Lehmann HE, Ban TA.
    Curr Ther Res Clin Exp; 1970 Sep 16; 12(9):598-603. PubMed ID: 4989691
    [No Abstract] [Full Text] [Related]

  • 32. Drug monitoring at an Australia depot phenothiazine clinic.
    Marriott P, Hiep A.
    J Clin Psychiatry; 1978 Mar 16; 39(3):206-12. PubMed ID: 580271
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Institutional management of chronic schizophrenics with fluphenazine decanoate.
    Neal CD, Imlah NW.
    Dis Nerv Syst; 1970 Sep 16; 31():Suppl:24-7. PubMed ID: 4920310
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J, Woggon B.
    Arzneimittelforschung; 1975 Feb 16; 25(2):267-70. PubMed ID: 1091272
    [Abstract] [Full Text] [Related]

  • 39. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB, Minsker EI, Mazaeva NA, Volkova RP, Lukanina SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Feb 16; 72(6):912-20. PubMed ID: 5050051
    [No Abstract] [Full Text] [Related]

  • 40. Psychophamacological treatment.
    Marriott P.
    Schizophr Bull; 1976 Feb 16; 2(4):505-6. PubMed ID: 1019592
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.